Publications by authors named "Ann Cheng"

Claim this Profile
I
Intersectionality of inequalities in revascularization and outcomes for acute coronary syndrome in England: nationwide linked cohort study.
Marius Roman, Ann Cheng, Florence Y Lai, Hardeep Aujla, Julie Sanders

Eur Heart J Qual Care Clin Outcomes· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sub-optimal Internal Mammary Grafts: Incidence, Timing, and Etiology.
Eron Yones, Ann Cheng, Arfah Hazel Preston, Mohsin Gondal, Tom Slater

Angiology· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying trusted local sources and predicting behavior change pathways according to COVID-19 vaccination status: Results of a 2022 statewide survey of Alaskan adults.
Drew B Cameron, Laura Grage, Rebecca Van Wyck, Alexandra Edwards, Joy Chavez Mapaye, Ann Cheng

Vaccine· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antithrombotic therapy after heart valve intervention: review of mechanisms, evidence and current guidance.
Ann Cheng, Christopher Malkin, Norman Paul Briffa

Heart· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy.
George Lau, Ming-Lung Yu, Grace Wong, Alexander Thompson, Hasmik Ghazinian, Gregory Cheng, Ann Lii Cheng

Hepatol Int· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elexacaftor, tezacaftor and ivacaftor: a case of severe rash and approach to desensitisation.
Ann Cheng, Olivia Baker, Uta Hill

BMJ Case Rep· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy.
George Lau, Ming-Lung Yu, Grace Wong, Alexander Thompson, Hasmik Ghazinian, Gregory Cheng, Ann Lii Cheng

Hepatol Int· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab plus Bevacizumab versus Sorafenib in the Chinese Subpopulation with Unresectable Hepatocellular Carcinoma: Phase 3 Randomized, Open-Label IMbrave150 Study.
Shukui Qin, Zhenggang Ren, Yin-Hsun Feng, Thomas Yau, Baocheng Wang, Ann Lii Cheng

Liver Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sternal Reconstruction Using Customized 3D-Printed Titanium Implants.
Mohamed K Kamel, Ann Cheng, Bruna Vaughan, Brendon Stiles, Nasser Altorki

Ann Thorac Surg· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements.
Masatoshi Kudo, Kwang-Hyub Han, Sheng-Long Ye, Jian Zhou, Yi-Hsiang Huang, Ann Lii Cheng

Liver Cancer· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aspirin therapy discontinuation and intraoperative blood loss in spinal surgery: a systematic review.
Ann Cheng, Michael T C Poon, Andreas K Demetriades

Neurosurg Rev· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computational and experimental investigation of constitutive behavior in AraC.
Mary Lowe, David Gullotti, Ana Damjanovic, Ann Cheng, Stephanie Dirla

Proteins· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re-evaluating transarterial chemoembolization for the treatment of hepatocellular carcinoma: Consensus recommendations and review by an International Expert Panel.
Ann Lii Cheng, Deepak Amarapurkar, Yee Chao, Pei-Jer Chen, Jean-François Geschwind

Liver Int· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.
Masao Omata, Laurentius A Lesmana, Ryosuke Tateishi, Pei-Jer Chen, Shi-Ming Lin, Ann Lii Cheng

Hepatol Int· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study.
Sandrine Faivre, Eric Raymond, Eveline Boucher, Jean Douillard, Ho Y Lim, Ann Lii Cheng

Lancet Oncol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sorafenib for the treatment of hepatocellular carcinoma across geographic regions.
Chiun Hsu, Ying-Chun Shen, Ann Lii Cheng

Expert Rev Clin Pharmacol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells.
Shuang En Chuang, Pei Yen Yeh, Yen Shen Lu, Gi Ming Lai, Chao Ming Liao, Ann Lii Cheng

Biochem Pharmacol· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis